Quick survey for European hospital pharmacists & heads of pharmacy

NANOSPRESSO, the European initiative advancing the local preparation of high-quality, personalised nucleic-acid nanomedicines—is launching a European Hospital Pharmacy Compounding Survey (accessible here) to map readiness for advanced therapy medicinal products (ATMPs) and cell & gene therapies (CGT). In collaboration with the Erasmus School of Health Policy & Management (Erasmus University Rotterdam) and Utrecht University, this short study will capture compounding capacity, expertise, workforce and infrastructure, as well as bottlenecks and policy needs across Europe. The evidence will guide training, investment and regulation, helping hospital pharmacies safely scale sterile compounding and build a resilient pharmacy of the future.

Start the survey → https://erasmusuniversity.eu.qualtrics.com/jfe/form/SV_a2Unuys9W4NqPoG

Why this matters

Advanced therapies (ATMPs/CGT) are accelerating. Europe needs a clear picture of hospital compounding capacity to plan training, infrastructure and policy. Your input will directly inform this picture.

What you’ll contribute

• Showcase your organisation’s expertise in compounding
• Reveal bottlenecks & needs across Europe
• Strengthen the profession’s voice with evidence for decision-makers
• Prepare for future demand in advanced therapies

Who should respond
Hospital pharmacists and heads of hospital pharmacy working in Europe (public or private).

Time commitment
A short questionnaire: ~7 minutes.

Confidentiality
Responses are analysed in aggregate; no individual institution will be identified in public outputs.

Partners
This survey is a collaboration between NANOSPRESSO, Erasmus School of Health Policy & Management (Erasmus University Rotterdam) and Utrecht University.

Questions?
Contact Joyce Hoek – j.m.hoek@uu.nl

Please share our survey with your colleagues.

After completing the survey, please share this page with heads of hospital pharmacy, national hospital-pharmacy networks and professional societies to broaden participation. Post on LinkedIn and tag @NANOSPRESSO, #HospitalPharmacy #Compounding #ATMPs #CGTReadiness, or forward the link by email to colleagues: your amplification will directly improve the representativeness and impact of the results! Thank you very much in advance.

Not an expert ? Here’s a 20-sec summary!

• Compounding = hospital pharmacists make patient-specific medicines in small, tightly controlled batches.
• Advanced therapies (e.g., nucleic-acid nanomedicines) often need fresh, precise, sterile prep close to patients.
• NANOSPRESSO develops a next-gen, GMP-aligned compounding model inside hospital pharmacies, so personalised nanomedicines reach patients safely, quickly, consistently